Benedetta Guani

Publications | Phd and Masters theses

Advanced search is available through Serval

Publications can be managed by accessing Serval via MyUnil


27 publications

2023 | 2022 | 2021 | 2020 | 2019 | 2011 | 2009 | 2008 |
Predictors of Non-Sentinel Lymph Node Metastasis in Patients with Positive Sentinel Lymph Node in Early-Stage Cervical Cancer: A SENTICOL GROUP Study.
Pache B., Tantari M., Guani B., Mathevet P., Magaud L., Lecuru F., Balaya V., SENTICOL Group, 2023/09/26. Cancers, 15 (19) p. 4737. Peer-reviewed.
 
Application en France des recommandations européennes 2021 sur le cancer de l’endomètre [Application in France of the 2021 European recommendations on endometrial cancer]
Deluche E., Marti C., Jochum F., Bendifallah S., Azaïs H., Deidier J., Cockenpot V., Menoux I., Kissel M., Balaya V. et al., 2023/01. Bulletin du cancer, 110 (1) pp. 55-68. Peer-reviewed.
 
Laparoscopic vaginal radical trachelectomy in the post-LACC era: step-by-step surgical procedure.
Guani B., Balaya V., Ayoubi J.M., Feki A., Lecuru F.R., Mathevet P., 2022/12/05. International journal of gynecological cancer, 32 (12) pp. 1617-1618. Peer-reviewed.
Management of Endometrial Cancer: French Society of Onco-Gynecology's Evaluation through a Delphi Survey.
Marti C., Deluche E., Jochum F., Bendifallah S., Azais H., Deidier J., Cockenpot V., Menoux I., Balaya V., Betrian S. et al., 2022/11/15. Journal of clinical medicine, 11 (22) p. 6765. Peer-reviewed.
 
Surgical management of patients with advanced ovarian cancer: Results of a French National Survey.
Gauci P.A., Deluche E., Azais H., Zaccarini F., Guani B., Balaya V., Kerbage Y., Jochum F., Sanson C., Guyon F. et al., 2022/11. Journal of gynecology obstetrics and human reproduction, 51 (9) p. 102463. Peer-reviewed.
 
Clinical impact of low-volume lymph node metastases in early-stage cervical cancer: A comprehensive meta-analysis.
Guani B., Mahiou K., Crestani A., Cibula D., Buda A., Gaillard T., Mathevet P., Kocian R., Sniadecki M., Wydra D.G. et al., 2022/02. Gynecologic oncology, 164 (2) pp. 446-454. Peer-reviewed.
Lymph Node Involvement in Early-Stage Cervical Cancer: Is Lymphangiogenesis a Risk Factor? Results from the MICROCOL Study.
Tantari M., Bogliolo S., Morotti M., Balaya V., Bouttitie F., Buenerd A., Magaud L., Lecuru F., Guani B., Mathevet P. et al., 2022/01/02. Cancers, 14 (1) p. 212. Peer-reviewed.
Estimation risk of lymph nodal invasion in patients with early-stage cervical cancer: Cervical cancer application.
Guani B., Gaillard T., Teo-Fortin L.A., Balaya V., Feki A., Paoletti X., Mathevet P., Plante M., Lecuru F., 2022. Frontiers in oncology, 12 p. 935628. Peer-reviewed.
Long-term oncological safety of sentinel lymph node biopsy in early-stage cervical cancer: A post-hoc analysis of SENTICOL I and SENTICOL II cohorts.
Balaya V., Guani B., Morice P., Querleu D., Fourchotte V., Leblanc E., Daraï E., Baron M., Marret H., Levêque J. et al., 2022/01. Gynecologic oncology, 164 (1) pp. 53-61. Peer-reviewed.
Can Conization Specimens Predict Sentinel Lymph Node Status in Early-Stage Cervical Cancer? A SENTICOL Group Study.
Balaya V., Guani B., Mereaux J., Magaud L., Pache B., Bonsang-Kitzis H., Ngô C., Desseauve D., Mathevet P., Lécuru F. et al., 2021/10/29. Cancers, 13 (21) p. 5423. Peer-reviewed.
ASO Author Reflections: Validation Based on Low-Volume Metastasis of the Sentinel Lymph Node Biopsy in Early-Stage Cervical Cancer.
Guani B., Mathevet P., 2021/07. Annals of surgical oncology, 28 (7) p. 3636. Peer-reviewed.
Histopathologic Validation of the Sentinel Node Technique for Early-Stage Cervical Cancer Patients.
Mathevet P., Guani B., Ciobanu A., Lamarche E.M., Boutitie F., Balaya V., Lecuru F., 2021/07. Annals of surgical oncology, 28 (7) pp. 3629-3635. Peer-reviewed.
 
Sentinel lymph node in cervical cancer: time to move forward.
Balaya V., Guani B., Pache B., Durand Y.G., Bonsang-Kitzis H., Ngô C., Mathevet P., Lécuru F., 2021/04. Chinese clinical oncology, 10 (2) p. 18. Peer-reviewed.
Validation of the 2018 FIGO Classification for Cervical Cancer: Lymphovascular Space Invasion Should Be Considered in IB1 Stage.
Balaya V., Guani B., Magaud L., Bonsang-Kitzis H., Ngô C., Mathevet P., Lécuru F., On Behalf Of The Senticol Group Group, 2020/11/28. Cancers, 12 (12) pp. E3554. Peer-reviewed.
Traitement du cancer débutant du col de l’utérus : retour vers le future [Treatment of early cervical cancer : Back to the future]
Guani B., Balaya V., Mathevet P., 2020/10/28. Revue medicale suisse, 16 (712) pp. 2046-2049. Peer-reviewed.
 
Diagnostic value of frozen section examination of sentinel lymph nodes in early-stage cervical cancer at the time of ultrastaging
Balaya V., Guani B., Benoit L., Magaud L., Bonsang-Kitzis H., Ngô C., Le Frère-Belda M.A., Mathevet P., Lécuru F., 2020/09. Gynecologic Oncology, 158 (3) pp. 576-583.
 
Diagnostic value of frozen section examination of sentinel lymph nodes in early-stage cervical cancer at the time of ultrastaging.
Balaya V., Guani B., Benoit L., Magaud L., Bonsang-Kitzis H., Ngô C., Le Frère-Belda M.A., Mathevet P., Lécuru F., 2020/09. Gynecologic oncology, 158 (3) pp. 576-583. Peer-reviewed.
 
Pre-operative surgical algorithm: sentinel lymph node biopsy as predictor of parametrial involvement in early-stage cervical cancer
Balaya Vincent, Bresset Arnaud, Guani Benedetta, Benoit Louise, Magaud Laurent, Bonsang-Kitzis Hélène, Ngo Charlotte, Mathevet Patrice, Lécuru Fabrice, 2020/09. International Journal of Gynecologic Cancer, 30 (9) pp. 1317-1325.
Nomogram Predicting the Likelihood of Parametrial Involvement in Early-Stage Cervical Cancer: Avoiding Unjustified Radical Hysterectomies.
Benoit L., Balaya V., Guani B., Bresset A., Magaud L., Bonsang-Kitzis H., Ngô C., Mathevet P., Lécuru F., 2020/07/05. Journal of clinical medicine, 9 (7) p. 2121. Peer-reviewed.
 
Place du ganglion sentinelle dans les cancers du col utérin débutants [Sentinel lymph node biopsy in early-stage cervical cancer: current state of art]
Balaya V., Guani B., Bonsang-Kitzis H., Deloménie M., Ngô C., Montero Macias R., Koual M., Nguyen-Xuan H.T., Bats A.S., Mathevet P. et al., 2020/06. Bulletin du cancer, 107 (6) pp. 696-706. Peer-reviewed.
The Clinical Impact of Low-Volume Lymph Nodal Metastases in Early-Stage Cervical Cancer: The Senticol 1 and Senticol 2 Trials.
Guani B., Balaya V., Magaud L., Lecuru F., Mathevet P., 2020/04/25. Cancers, 12 (5) p. 1061. Peer-reviewed.
 
Risk factors for failure of bilateral sentinel lymph node mapping in early-stage cervical cancer.
Balaya V., Bresset A., Guani B., Magaud L., Montero Macias R., Delomenie M., Bonsang-Kitzis H., Ngô C., Bats A.S., Mathevet P. et al., 2020/01. Gynecologic oncology, 156 (1) pp. 93-99. Peer-reviewed.
Sentinel Lymph-Node Biopsy in Early-Stage Cervical Cancer: The 4-Year Follow-Up Results of the Senticol 2 Trial.
Favre G., Guani B., Balaya V., Magaud L., Lecuru F., Mathevet P., 2020. Frontiers in oncology, 10 p. 621518. Peer-reviewed.
 
Impact of micrometastasis or isolated tumor cells on recurrence and survival in patients with early cervical cancer: SENTICOL Trial.
Guani B., Dorez M., Magaud L., Buenerd A., Lecuru F., Mathevet P., 2019/03. International journal of gynecological cancer, 29 (3) pp. 447-452. Peer-reviewed.
 
FSH-receptor Ala307Thr polymorphism is associated to polycystic ovary syndrome and to a higher responsiveness to exogenous FSH in Italian women
Dolfin Elisabetta, Guani Benedetta, Lussiana Cristina, Mari Caterina, Restagno Gabriella, Revelli Alberto, 2011/09. Journal of Assisted Reproduction and Genetics, 28 (10) pp. 925-930.
 
Ovarian hyper-stimulation syndrome after spontaneous conception.
Lussiana C., Guani B., Restagno G., Rovei V., Menato G., Revelli A., Massobrio M., 2009/07. Gynecological endocrinology, 25 (7) pp. 455-459. Peer-reviewed.
 
Mutations and polymorphisms of the FSH receptor (FSHR) gene: clinical implications in female fecundity and molecular biology of FSHR protein and gene.
Lussiana C., Guani B., Mari C., Restagno G., Massobrio M., Revelli A., 2008/12. Obstetrical & gynecological survey, 63 (12) pp. 785-795. Peer-reviewed.
Partagez:
Unicentre - CH-1015 Lausanne
Suisse
Tél. +41 21 692 11 11
Swiss University